Common Stock, Shares, Outstanding of Karyopharm Therapeutics Inc. from 31 Dec 2012 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Karyopharm Therapeutics Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2012 to 31 Dec 2025.
  • Karyopharm Therapeutics Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 18,311,000, a 118% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Karyopharm Therapeutics Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 18,311,000 +9,898,000 +118% 31 Dec 2025 10-K 13 Feb 2026 2025 FY
Q3 2025 8,702,000 -116,601,000 -93% 30 Sep 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 8,647,000 -115,988,000 -93% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 8,568,000 -107,889,000 -93% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 8,413,000 -106,502,000 -93% 31 Dec 2024 10-K 13 Feb 2026 2025 FY
Q3 2024 125,303,000 +10,780,000 +9.4% 30 Sep 2024 10-Q 05 Nov 2024 2024 Q3
Q2 2024 124,635,000 +10,295,000 +9% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 116,457,000 +2,486,000 +2.2% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 114,915,000 +1,702,000 +1.5% 31 Dec 2023 10-K 19 Feb 2025 2024 FY
Q3 2023 114,523,000 +33,496,000 +41% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 114,340,000 +34,542,000 +43% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 113,971,000 +34,552,000 +44% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 113,213,000 +37,467,000 +49% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 81,027,000 +5,525,000 +7.3% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 79,798,000 +4,464,000 +5.9% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 79,419,000 +4,357,000 +5.8% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 75,746,000 +1,823,000 +2.5% 31 Dec 2021 10-K 17 Feb 2023 2022 FY
Q3 2021 75,502,000 +1,974,000 +2.7% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 75,334,000 +1,968,000 +2.7% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 75,062,000 +1,967,000 +2.7% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 73,923,000 +8,553,000 +13% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 73,528,000 +10,822,519 +17% 30 Sep 2020 10-Q 02 Nov 2020 2020 Q3
Q2 2020 73,366,000 +12,400,495 +20% 30 Jun 2020 10-Q 04 Aug 2020 2020 Q2
Q1 2020 73,095,000 +12,230,555 +20% 31 Mar 2020 10-Q 05 May 2020 2020 Q1
Q4 2019 65,370,000 +4,540,692 +7.5% 31 Dec 2019 10-K 24 Feb 2021 2020 FY
Q3 2019 62,705,481 +2,040,624 +3.4% 30 Sep 2019 10-Q 04 Nov 2019 2019 Q3
Q2 2019 60,965,505 +464,245 +0.77% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 60,864,445 +11,194,117 +23% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 60,829,308 +11,296,158 +23% 31 Dec 2018 10-K 26 Feb 2020 2019 FY
Q3 2018 60,664,857 +13,510,653 +29% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 60,501,260 +13,378,052 +28% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 49,670,328 +7,768,073 +19% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 49,533,150 +7,645,321 +18% 31 Dec 2017 10-K 28 Feb 2019 2018 FY
Q3 2017 47,154,204 +7,430,201 +19% 30 Sep 2017 10-Q 02 Nov 2017 2017 Q3
Q2 2017 47,123,208 +11,133,948 +31% 30 Jun 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 41,902,255 +5,977,517 +17% 31 Mar 2017 10-Q 04 May 2017 2017 Q1
Q4 2016 41,887,829 +6,023,064 +17% 31 Dec 2016 10-K 15 Mar 2018 2017 FY
Q3 2016 39,724,003 +4,012,053 +11% 30 Sep 2016 10-Q 07 Nov 2016 2016 Q3
Q2 2016 35,989,260 +285,842 +0.8% 30 Jun 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 35,924,738 +237,542 +0.67% 31 Mar 2016 10-Q 09 May 2016 2016 Q1
Q4 2015 35,864,765 +3,165,385 +9.7% 31 Dec 2015 10-K 16 Mar 2017 2016 FY
Q3 2015 35,711,950 +3,097,563 +9.5% 30 Sep 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 35,703,418 +5,982,996 +20% 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 35,687,196 +6,068,317 +20% 31 Mar 2015 10-Q 11 May 2015 2015 Q1
Q4 2014 32,699,380 +3,112,122 +11% 31 Dec 2014 10-K 15 Mar 2016 2015 FY
Q3 2014 32,614,387 +30,023,054 +1159% 30 Sep 2014 10-Q 10 Nov 2014 2014 Q3
Q2 2014 29,720,422 30 Jun 2014 10-Q 07 Aug 2014 2014 Q2
Q1 2014 29,618,879 31 Mar 2014 10-Q 08 May 2014 2014 Q1
Q4 2013 29,587,258 +27,463,870 +1293% 31 Dec 2013 10-K 13 Mar 2015 2014 FY
Q3 2013 2,591,333 30 Sep 2013 10-Q/A 23 Dec 2013 2013 Q3
Q4 2012 2,123,388 31 Dec 2012 10-K 21 Mar 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.